API合同制造市场将迎来繁荣 |• 龙沙 • 卡塔伦特 - openPR.com
Api Contract Manufacturing Market Is Going to Boom |• Lonza • Catalent - openPR.com
生命科学资讯
生物技术与制药领域的最新动态
填充完成制造市场分析报告2026-2035：预计2030年市场规模超210亿美元，强生、艾伯维、赛默飞世尔科技、BD公司、百特、龙沙及Catalent领跑市场 - 雅虎财经
Fill Finish Manufacturing Market Analysis Report 2026-2035: A $21+ Billion Market by 2030 with Johnson & Johnson, AbbVie, Thermo Fisher Scientific, BD & Co, Baxter, Lonza, and Catalent Leading - Yahoo Finance
填充完成制造市场分析报告2026-2035：预计2030年市场规模超210亿美元，强生、艾伯维、赛默飞世尔科技、BD公司、百特、龙沙及Catalent领跑市场 - 雅虎财经加拿大版
Fill Finish Manufacturing Market Analysis Report 2026-2035: A $21+ Billion Market by 2030 with Johnson & Johnson, AbbVie, Thermo Fisher Scientific, BD & Co, Baxter, Lonza, and Catalent Leading - Yahoo! Finance Canada
Catalent计划关闭比利时细胞疗法生产基地
Catalent plans to close Belgium cell therapy site
2021-2025年全球对照药品采购市场回顾与2026-2031年预测报告——聚焦Clinigen、BAP Pharma Group、赛默飞世尔科技、美国实验室公司、Catalent等企业 - 雅虎财经新加坡版
Comparator Drug Sourcing Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Clinigen, BAP Pharma Group, Thermo Fisher Scientific, Laboratory Corporation of America, Catalent and More - Yahoo Finance Singapore
Catalent收到两份483表格，涉及Sarepta基因疗法基地问题。
Catalent handed two Form 483s, including for Sarepta gene therapy site
诺和诺德因收购的Catalent工厂收到FDA警告信。
Novo Nordisk hit with FDA warning letter over acquired Catalent factory
龙沙集团、Catalent与Recipharm领跑125亿美元吸入药物合同制造市场 - pharmiweb.com
Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Mar - pharmiweb.com
龙沙集团、Catalent与Recipharm引领2025-2033年125亿美元吸入药物合同制造市场：按服务、产品、终端用途及区域分析——ResearchAndMarkets.com - AI期刊
Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Market, 2025-2033: Insights by Service, Product, End-Use and Region - ResearchAndMarkets.com - The AI Journal